Market
Scenario:
Cheilectomy
is a surgical procedure aimed to remove the bony lump present on the top of the
metatarsophalangeal joint (big toe). Hallux rigidus, a type of big toe
arthritis is a major cause of the same. According to a study published in the
World Journal of Orthopedics in 2017, hallux rigidus is a degenerative disease
of the first MTP joint. Moreover, it is estimated that the disease affects 1 in
every 40 people, aged 50 or more. Females are greatly affected by the disease
as compared to males, .i.e., by a ratio of 2:1. Therefore, increasing
prevalence of hallux rigidus and growing female population are the major drivers
for the market growth during the forecast period.
Additionally,
increasing demands for minimally invasive procedures and rising healthcare
expenditure is estimated to fuel the market. According to the World Health
Organization, the geriatric population is projected to grow from an estimated
524 million in 2010 to approximately 1.5 billion by 2050. However, high
procedural cost followed by complications like deep vein thrombosis, need for
repeated surgery, stiffness in the joints of the toes and low per capita
healthcare expenditure in the middle and low-income countries is estimated to
restrain the market growth during the projected period. According to the
Fairfield Independent Hospital, the procedural cost for the same in 2016 was
estimated to be around USD 3,545.
The
global cheilectomy market is expected to grow at a CAGR of 7.8% during the
forecast period.
Segmentation:
The
global cheilectomy market is segmented by the method, anesthesia, medication,
and end-user.
By the
method, the market is segmented into open, arthroscopic, and percutaneous
method.
By the
anesthesia, the market is categorized into general anesthesia, local
anesthesia, and regional anesthesia. By the medication, the market is segmented
into prescription pain relievers, OCT, and others. By prescription the pain
relievers the market is segmented into corticosteroids, opioids, nonsteroidal
anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is
segmented into ibuprofen, naproxen, and others. By end users, the market is
segmented into hospitals & clinics, academic institutes, retail pharmacies,
and others.
Regional
Analysis:
The
Americas dominate the global cheilectomy market owing to a well-developed
healthcare sector and increasing the prevalence of hallux rigidus. Moreover,
increasing healthcare expenditure and presence of the key players within the
regions boosts the growth of the market in the Americas. Additionally,
increasing geriatric population and growing female population fuels the
regional market growth.
Europe is
the second largest cheilectomy market, which is followed by Asia Pacific.
Osteoarthritis is a common condition that may lead to hallux rigidus. Thus,
increasing prevalence of the disease within the region drives the market
growth. According to the Arthritis Research U.K in 2013, osteoarthritis was estimated
to be the most common musculoskeletal condition in the geriatric population.
Additionally, it was estimated that approximately, 8.75 million people within
the region had sought some treatment for osteoarthritis.
Asia
Pacific is the fastest growing region for the market due to the presence of a
huge patient population, continuously developing economies like India &
China, and presence of huge opportunity in the market.
On the
other hand, the Middle East & Africa has the least share in the global cheilectomy
market due to the presence of poor economy, especially in the Africa region.
Majority of the market of this region is held by the Middle East due to a
well-developed healthcare sector and huge healthcare expenditure.
Browse Complete 90 Pages Premium Research Report
Enabled with 86 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cheilectomy-market-5470
Key Players in Global Cheilectomy Market
The key
players for the global cheilectomy market are Henry Schein, Inc. (U.S.), Pfizer
Inc. (U.S.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), STEROID
S.p.A. (Italy), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium),
PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim
International GmbH (Germany), and others.
Detailed Table
of Contents:
Chapter
1. Report Prologue
Chapter
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment